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ABSTRACT
Oligonucleotide models of ribosomal RNA domains
are powerful tools to study the binding and molecu-
lar recognition of antibiotics that interfere with
bacterial translation. Techniques such as select-
ive chemical modification, fluorescence labeling
and mutations are cumbersome for the whole
ribosome but readily applicable to model RNAs,
which are readily crystallized and often give rise to
higher resolution crystal structures suitable for
detailed analysis of ligand–RNA interactions. Here,
we have investigated the HX RNA construct which
contains two adjacent ligand binding regions of
helix h44 in 16S ribosomal RNA. High-resolution
crystal structure analysis confirmed that the HX
RNA is a faithful structural model of the ribosomal
target. Solution studies showed that HX RNA
carrying a fluorescent 2-aminopurine modification
provides a model system that can be used to
monitor ligand binding to both the ribosomal
decoding site and, through an indirect effect, the
hygromycin B interaction region.
INTRODUCTION
Aminoglycosides are natural products that bind to the
small (30S) ribosomal subunit and interfere with bacterial
translation. A highly substituted cyclohexane scaffold,
2-deoxystreptamine (2-DOS), which is conserved among
structurally diverse aminoglycosides, confers specific
RNA recognition (Figure 1) (1–3). Compounds from the
two largest families of aminoglycosides, including
neomycin and kanamycin, bind to the ribosomal
decoding site (A-site) at an internal loop of helix h44
in 16S rRNA and reduce fidelity of mRNA translation
(4,5). At least three other distinct binding sites for
aminoglycosides of unusual structure exist in the 30S
subunit (6). These include hygromycin B, streptomycin
and spectinomycin. Hygromycin B, an aminoglycoside
with a unique spiro-acetal structure (Figure 1), binds to
a region of h44 immediately adjacent to the decoding site
loop (4,7,8) and primarily inhibits translocation of mRNA
and tRNAs on the ribosome but only marginally impacts
decoding fidelity (8,9). Unlike the A-site target of
aminoglycoside antibiotics, which harbors specific
sequence differences between bacteria and eukaryotes,
the hygromycin B binding site is conserved between
lineages (Figure 1). While the utility of decoding
site-binding aminoglycosides as antibiotics emerges from
a combination of discrimination for the bacterial target
RNA as well as their inability to permeate mammalian
cells (10), hygromycin B lacks bacterial target specificity
(11), preventing its use in anti-infective therapy but ren-
dering it a widely used tool compound for selection in cell
culture.
The adjacency of the hygromycin B binding region to
the decoding site target of the neomycin and kanamycin
antibiotics had inspired the design of aminoglycoside
hybrid ligands that were conceived to bridge between the
two sites and thereby interfere with ribosomal function
(12). A first generation of hybrid ligands was synthesized
that had activity as inhibitors of bacterial translation,
however, none of the compounds showed potency
superior to the natural aminoglycosides. Here, we
investigated the bipartite HX oligonucleotide (Figure 1)
as a target model for the adjacent aminoglycoside
binding sites in helix h44 to support the discovery of syn-
thetic antibacterial ligands. Similar RNA models, consist-
ing of two oligonucleotides with distinct sequences, as well
as ‘dimeric’ constructs which are formed from two identi-
cal strands and contain two decoding sites (13), have been
widely used to study high-resolution structure, dynamics
and drug binding of the ribosomal decoding site (14,15).
In this contribution, we describe fluorescence labeling in
solution as well as X-ray crystallographic structure deter-
mination of HX RNA as a model of the aminoglycoside
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antibiotic binding region in helix h44. Our goals were to
obtain a high-resolution crystal structure for the HX
RNA, which could be compared to the h44 structure in
the ribosome, and to demonstrate aminoglycoside binding
to the model RNA. We show that, similar to the smaller
decoding site, the HX RNA can be used as a faithful
model of the extended aminoglycoside binding region of
h44 that retains dynamic and ligand binding characteris-
tics of the ribosomal target.
MATERIALS AND METHODS
RNA and aminoglycosides
Gel-purified and desalted synthetic oligonucleotides
(HX-A: 50-CCG CGC CCG UCA CAC CAC CCG;
HX-B: 50-GGG UGG UGA AGU CGU AAC GCG
GC) as well as brominated derivatives [HX-ABr: 5
0-CCG
CGC CCG (5-Br-U)CA CAC CAC CCG; HX-BBr:
50-GGG (5-Br-U)GG UGA AGU CGU AAC GCG GC]
Figure 1. Aminoglycosides and the ribosomal RNA helix h44 target. (a) Aminoglycosides of the neomycin and kanamycin families as well as
hygromycin B share in common a conserved 2-deoxystreptamine (2-DOS) ring (highlighted in blue). (b) Overlay of crystal structures showing
paromomycin (green) and hygromycin B (orange) bound to the h44 RNA (7,29). (c) Secondary structure of h44 in 16S rRNA which contains
the decoding site loop (A1408/A1492/A1493). Residues that differ between the bacterial and eukaryotic sequence are in bold. Binding regions for
aminoglycosides are marked in color: neomycin and kanamycin families, green; hygromycin B, orange. (d) Secondary structure of the HX RNA
construct used in this work for crystallization and solution binding studies.
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and 2AP-labeled RNA were purchased from Dharmacon
(Lafayette, CO). Oligonucleotides HX-A and HX-B were
reconstituted without further purification in 10mM
sodium cacodylate buffer, pH 6.5, mixed and annealed
by heating to 75C followed by snap cooling on ice to
give reconstituted HX RNA. Aminoglycosides were
purchased as sulfates from Sigma (St Louis, MO) and
used without further purification.
Crystallization and X-ray diffraction data collection
For crystallization of HX RNA by hanging drop vapor
diffusion, 1 ml of 0.2mMHX RNA in annealing buffer was
mixed with an equal amount of precipitating solution con-
taining 50mM sodium cacodylate pH 6.5, 1mM magne-
sium chloride and 1.95M ammonium sulfate. Hexagonal
pyramidal-shaped crystals grew within two days at 16C
after equilibration against 700 ml of well solution contain-
ing 1.95M ammonium sulfate. Crystals were soaked for
30 s in a cryoprotectant buffer containing the original
reservoir solution as well as 20% PEG 200 and
flash-cooled in liquid nitrogen. Diffraction data were col-
lected in a nitrogen stream at 100K on beamline 17-ID at
the Advanced Photon Source (APS), Argonne National
Laboratory (IL). Two hundred images were collected at
a crystal-to-detector distance of 20 cm with an exposure
time of 10 s per frame with 1 oscillation. Data were pro-
cessed, integrated and scaled with the HKL2000 package
(Table 1) (16).
Structure solution and refinement
Phases were calculated from single-wavelength anomalous
diffraction data of the brominated RNA derivative using
the CNS suite of programs (17,18). After positions of
heavy atoms were identified, an electron density map
was calculated that guided the manual construction of
an initial three-dimensional structure model of the RNA
in Coot (19). The orientation and position of this model
were refined by rigid body refinement with each chain as a
rigid group in the program Refmac (20) within the CCP4
package (21). The structure was further refined using
several rounds of restrained minimization in Refmac and
manual rebuilding in Coot based on the obtained 2FoFc
and FoFc maps. During the model rebuilding, three
magnesium cations and two sulfate anions were placed
based on electron density. The progress of the model re-
building and refinement was monitored using Rfree, which
was calculated from a randomly chosen test set comprising
4.6% of the data. Final refinement was carried out with
the PHENIX software (22) using combined TLS and
individual isotropic atomic displacement parameters
(Table 1). During the last cycles, the water picking
protocol in PHENIX was added. The refined structure
has been deposited with the Protein Data Bank (accession
code 3LOA).
UV melting
UV melting experiments were performed on a
thermostatted UV-2401PC spectrofluorometer
(Shimadzu, Columbia, MD) according to established pro-
cedures (23). RNA at 750 nM concentration in 10mM
sodium cacodylate buffer, pH 6.5, was heated from
25–85C at a rate of 0.25 degree/min. Depending on the
experiment, 6mM MgCl2 or 10 mM aminoglycoside were
present. RNA samples were covered with a thin layer of
silicone oil to prevent evaporation during heating.
Absorption was recorded at 260 nm every 6 s.
Fluorescence spectroscopy
Fluorescence measurements were performed on a
thermostatted RF-5301PC spectrofluorometer
(Shimadzu, Columbia, MD) at 25C. Emission spectra
were recorded in 10mM sodium cacodylate buffer, pH
6.5, at 1.5mM RNA concentration and while irradiating
at 310 nm (2AP). EC50 values were calculated with the
Sigmaplot software (Systat Software, Point Richmont,
CA) by fitting a dose response curve to the normalized
fluorescence intensity plotted versus the log of
aminoglycoside concentration. Normalized relative fluor-
escence was calculated by subtracting background signal
measured in a titration of compound into buffer and nor-
malization by the fluorescence intensity of the labeled free
RNA (24).
RESULTS AND DISCUSSION
Crystal structure of HX RNA
The three-dimensional structure of the HX RNA was
determined by X-ray crystallography at 2.3 A˚ resolution
(Table 1). A series of bipartite oligonucleotide constructs,
which comprised the ribosomal decoding site as well as the
Table 1. Data collection and refinement statistics for HX RNA
Data collection
Wavelength (A˚) 0.919411
Low-resolution limit (A˚) 2.3
High-resolution limit (A˚) 28.7
Redundancy 12.5 (12.2)
Completeness (%) 99.7 (100)
I/(I) 36.22 (5.31)
Total reflections 61 667
Unique reflections 4941
Refinement
Space group P64
Cell dimensions (A˚)
a 57.46
b 57.46
c 58.43
Rwork/Rfree 0.191/0.231
No. of atoms
RNA atoms 935
Solvent atoms 29
Metal ions 3 Mg2+
Anions 2 SO24
Mean B factors (A˚2)
RNA 57.84
Solvent 53.21
Metal 64.1
Anion 95.65
RMSD
Bond lengths (A˚) 0.007
Bond angles () 1.4
Dihedral angles () 17.11
Numbers in parentheses are for the highest-resolution shell.
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adjacent hygromycin binding region (Figure 1), were
screened for crystallization. Ultimately, the HX RNA
was chosen since it formed large crystals giving the best
diffraction quality. This RNA contains additional
terminal base pairs and 30 unpaired nucleotide overhangs
which facilitated packing in the crystal. The structure was
solved by using phases calculated from single-wavelength
anomalous diffraction of RNA containing two 5-bromo
substituted uridines (U1406, U1487). In the crystal, the
HX RNA adopts an overall straight double-stranded
helix (Figure 2). Pseudo-continuous stacking of neighbor-
ing helices is stabilized by intermolecular base pair
formation between complementary 30 overhanging nucleo-
tides. Three Mg2+ and two SO24 ions are present in the
crystal structure. One cation and anion each are located at
interfacial positions, participating in the crystal packing.
The internal loop of the decoding site, which is
comprised of the residues A1498, A1492 and A1493,
adopts a conformation that is distinct from the arrange-
ments seen in previously obtained structures of this region
in context of the whole 30S ribosomal subunit (25,26) and
similar model oligonucleotides that lacked the hygromycin
B binding region (15,27). Packing of HX RNA in the
crystal involves the A1492 base which is rotated away
Figure 2. Stereo views of the three-dimensional structure of HX RNA as determined by X-ray crystallography. (a) Overlay of the structure and the
2FoFc electron density map contoured at 1.5s. Only a core segment comprised of the decoding site loop and hygromycin B binding site is shown
(residues G1401–C1409 and G1491–C1501). Bases that are not part of Watson–Crick pairs are highlighted in color (compare secondary structure in
Figure 1d). (b) The upper stem region with non-canonical base interactions. (c) The decoding site internal loop with adenine residues highlighted in
red. A water molecule mediating the interaction between A1493 and the A1492 phosphate group is shown as blue sphere.
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from the helix and interacts with a neighboring RNA
molecule. The base of A1493 is oriented inside the minor
groove, filling the void opposite to A1408, where it is
stabilized by a single hydrogen bond between HN6 of
A1493 and N1 of A1408 as well as stacking on G1494
and a water-mediated contact to the phosphate group of
A1492. In structures of the decoding site in the ligand-free
state of whole 30S subunits (25,26), where the conform-
ation of residues in h44 is unaffected by crystal packing
interactions, A1492 is oriented inside the RNA helix and,
in one case (PDB ID 2AW2), forming a base pair with
A1408 (26), while A1493 has been found in either of two
states, rotated out or stacking inside on A1492. The pos-
itions of A1493 in the HX crystal structure and the
ribosome are similar. In oligonucleotide models of the
decoding site, the orientation of A1492 and A1493 is con-
strained by involvement of those residues in crystal
packing contacts, which may bear little relevance to the
conformational states in solution. An identical conform-
ation of the two sensor adenines as found in the HX
crystal structure has also been observed in the ‘empty’
decoding site of dimeric model constructs which were
complexed with aminoglycoside ligands at only one of
the two decoding sites (3,28). In addition to the three
adenines of the decoding site loop, residues that are
involved with aminoglycoside binding include the
C1407–G1494 and U1406 U1495 pairs. The geometry
of the non-canonical pair U1406 U1495, which
contains a bromo modification (5-Br-U1406) in the HX
RNA, is identical to that in the ribosome and decoding
site model oligonucleotides.
In the hygromycin B binding region, the arrangement of
bases corresponds to the secondary structure shown in
Figure 1c, which reflects the configuration found in
crystal structures of the ribosome and the 30S subunits
(25,26). Non-canonical base pairs occur between
co-planar residues C1402 and A1500 as well as C1403
and U1498. The base of A1499 docks at the minor
groove edge of the C1403 U1498 pair while forming
interactions with the purine of A1403 and the 20-OH
group of U1498. The flanking pairs G1401–C1501 and
C1404–G1497 adopt regular Watson–Crick geometries.
Superposition of HX RNA and the corresponding
region of h44 in the crystal structures of the ribosomal
30S subunit, free and in complex with the aminoglycoside,
reveals that the geometry of the hygromycin B binding site
is nearly identical in the model RNA and the ribosomal
subunit structures, attested by root mean square deviation
(RMSD) values of 1.1–1.2 A˚ (Figure 3). At the major
groove edge of the C1404–G1497 pair in the hygromycin
B binding site of the HX RNA, a Mg2+ ion is found which
is absent in crystal structures of the ligand-free 30S
subunit. Considering the relatively low concentration of
1mM Mg2+ in the crystallization conditions for HX
RNA, it is conceivable that this metal binding site is
physiologically relevant but not resolved in the crystal
structures of the whole ribosome and the 30S subunit.
The high similarity of the hygromycin B binding site
geometry in the HX RNA compared to whole 30S
subunits suggested that the small oligonucleotide might
provide a useful model system for the study of ligand
interactions at the ribosomal h44 helix. We next
investigated the impact of aminoglycoside and metal ion
binding on the thermal stability and conformational
mechanics of the decoding site in the HX RNA.
Impact of ligand binding on the stability of the HX RNA
hybrid
Thermal denaturation of HX RNA in buffer was moni-
tored by measuring absorption at 260 nm while heating in
the absence and presence of ligands (Figure 4a).
Monophasic melting profiles were recorded for the free
RNA and when hygromycin B or Mg2+ were present. A
biphasic denaturation transition was observed after
addition of paromomycin, a decoding site-binding
aminoglycoside related to neomycin B (Figure 1a). Both
aminoglycosides as well as Mg2+ led to increased melting
temperatures. In all cases, the temperature shift was sub-
stantial, which indicated stabilization of the HX RNA
Figure 3. Stereo view of a superposition of the hygromycin B binding site in HX RNA (white backbone) and the corresponding region in the crystal
structures of the ribosomal 30S subunit, free (orange, PDB 1J5E; RMSD=1.2 A˚) (25) and in complex with the aminoglycoside ligand (green, PDB
1HNZ; RMSD=1.1 A˚) (7). Color coding of bases in the HX structure is the same as in Figure 2. The positions of an Mg2+ ion (yellow) as well as a
bromine in 5-bromo uridine 1406 (blue) in the HX structure are indicated with spheres. RMSD values were calculated for superposition of residues
C1403–C1409 and G1494–U1498; RMSD of 1J5E versus 1HNZ=0.4 A˚.
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through binding of the ligands. Hygromycin B at 10 mM
increased the thermal stability of the RNA by 7C while
paromomycin at the same concentration had an even
greater effect. The occurrence of two transitions in the
denaturation profile suggested that a larger conformation-
al change precedes the dissociation of the oligonucleotide
hybrid complex for paromomycin but not for either
hygromycin B or Mg2+.
Solution studies of fluorescently labeled HX RNA
The conformationally flexible adenine residues A1492 and
A1493 play a key role in ribosomal decoding by acting as
molecular sensors that monitor the formation of a correct-
ly base-paired hybrid between the mRNA codon and the
tRNA anticodon (5). The bases of the sensor adenines
occupy positions inside or rotated out of the h44 helix.
The conformational transition into the ‘flipped out’ state
in which both A1492 and A1493 are rotated into the
decoding site space is observed when mRNA and
cognate tRNA are bound. The same transition is triggered
by binding of aminoglycosides of the neomycin and kana-
mycin families to the decoding site loop (29). It has been
suggested that aminoglycoside binding to the decoding site
RNA lowers the energy barrier for the conformational
transition of the sensor adenines and thereby interferes
with discrimination between cognate and near-cognate
anticodon interactions which ultimately increases the
error rate during translation (5,30). Replacement of
either A1492 or A1493 by fluorescent base analogs, such
as 2-aminopurine (2AP) or pteridines, in oligonucleotide
models of the decoding site has been used to study
conformational states of the adenine sensors and to
monitor conformational changes triggered by ligand
binding (24,27,31), including aminoglycosides. Here, we
have introduced 2AP as a fluorescent replacement of
A1493 in HX RNA. Titration of 2AP1493 labeled oligo-
nucleotide (HX-B) with increasing amounts of the com-
plementary strand (HX-A) resulted in a steady increase of
the 2AP fluorescence intensity up to a 1:1 strand ratio
(Figure 4b), indicating full hybridization. As has been
found before in model RNAs of the decoding site alone,
in the hybridized HX RNA, the 2AP1493 preferentially
adopted a conformation rotated out of the helix and
directed into the solvent which led to increased fluores-
cence compared with that generated from the random
coiled single strand (Figure 5, ‘free’ state) (24,27). With
respect to the decoding site conformational mechanics, the
HX RNA thus behaved undistinguishable to smaller
model systems which were lacking the hygromycin B
binding region.
We next tested the response of 2AP1493 labeled HX
RNA to addition of aminoglycosides and Mg2+. When
paromomycin was titrated to HX RNA, a decrease of
fluorescence occurred (Figure 4c), exactly as had been
observed for smaller model RNAs of the decoding site
(24,27,31). Upon binding of the aminoglycoside, A1492
is expelled from the internal loop and forced to stack on
the rotated-out 2AP1493 base, which leads to fluorescence
quenching (Figure 5, ‘Neo/Kan’ state). Similarly, titra-
tions of HX RNA with tobramycin, a decoding
site-binding aminoglycoside related to kanamycin
(Figure 1a), resulted in fluorescence quenching (data not
Figure 4. Solution studies of HX RNA. (a) UV melting profiles of HX RNA, free (blue; Tm=38.4
C) and in the presence of Mg2+ (6mM, light
green; Tm=56.4
C), hygromycin B (10 mM, orange; Tm=45.4C), or paromomycin (10 mM, green; Tm,1=41.5C, Tm,2=58.8C). (b) Fluorescence
of the 2AP label at position 1493 during formation of the HX RNA hybrid by titration of the 2AP-labeled single strand (HX-B) with increasing
amounts of the other oligonucleotide (HX-A). (c) Titrations of 2AP1493 labeled HX RNA with Mg2+ (light green, EC50=17±5 mM), hygromycin
B (orange, EC50=3.1±0.6 mM) or paromomycin (green, EC50=0.14±0.01mM). (d) Titrations of 2AP1493 labeled HX RNA with hygromycin B
in the presence of Mg2+ (black: 0; blue: 10 mM; green: 100mM; orange: 320 mM; red: 1000 mM).
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shown). The EC50 values of the dose response for fluores-
cence quenching by paromomycin (0.14±0.01 mM) and
tobramycin (1.5±0.10mM) were in good agreement
with values previously reported for 2AP1493 labeled
decoding site models (24,27,31). The HX construct thus
retained the binding characteristics of decoding site model
RNAs for aminoglycosides of the neomycin and kanamy-
cin families. While simple decoding site RNAs do not
monitor binding of hygromycin B, the HX RNA was re-
sponsive to this aminoglycoside, showing an increase of
fluorescence (Figure 4c), which suggested that a higher
exposure of the 2AP1493 label was induced by binding
of this compound. We speculate that binding of
hygromycin B to HX RNA led to reduced flexibility in
the adjacent decoding site loop and immobilization of
the sensor adenines in their more preferred conformations,
oriented inside the RNA for A1492 and rotated-out for
A1493, which resulted in an increase of fluorescence
(Figure 5, ‘Hyg’ state). Previous studies of fluorescently
labeled decoding site RNAs indicated that, in the
absence of stabilizing ligands, A1493 samples conform-
ational space in the interior and outside the RNA helix,
albeit with a preference for the rotated-out orientation
(24,27). Conformational flexibility of the decoding site
internal loop might be more pronounced in the HX
RNA due to the adjacent non-canonical base pairs.
Binding of hygromycin B at these non-canonical pairs
might stabilize the region above the decoding site loop
and thereby reduce conformational flexibility of the
sensor adenines. As a consequence, 2AP1493 is locked in
the rotated-out position where its fluorescence is increased
relative to free HX RNA. The orientation of A1492 and
A1493 supported by our fluorescence data is consistent
with the conformation of the sensor adenines observed
in the crystal structure of the full Escherichia coli
ribosome in complex with hygromycin B (8). A fluores-
cence increase was also observed when Mg2+ was added
(Figure 4c), although the metal required a higher concen-
tration to achieve the same effect as hygromycin B (EC50
values: Mg2+, 17±5 mM; hygromycin B, 3.1±0.6 mM).
Binding of hygromycin B, but not paromomycin, to HX
RNA was in direct competition with Mg2+ as
demonstrated by titration curves recorded in the
presence of increasing amounts of the metal (Figure 4d).
The HX RNA as a model for ligand binding studies at
ribosomal helix h44
While crystal structures are now available for the bacterial
ribosome, its subunits, and antibiotics complexes thereof,
small oligonucleotide models of ribosomal RNA remain
useful for investigations of RNA molecular recognition
and ligand screening. Powerful techniques such as select-
ive chemical modification, fluorescence labeling and
mutations are cumbersome for the whole ribosome but
readily applicable to model RNAs, which are readily
crystallized and often give rise to higher resolution
crystal structures suitable for detailed analysis of ligand–
RNA interactions. Here, we have shown that the HX
RNA is a useful model of two adjacent ligand binding
regions in the ribosomal RNA helix h44. High-resolution
crystal structure analysis confirmed that the HX RNA is a
faithful structural model of the ribosomal target. Solution
studies showed that HX RNA carrying a fluorescent
2AP1493 modification provides a model system that can
be used to monitor ligand binding to both the ribosomal
decoding site and, through an indirect effect, the
hygromycin B interaction region (Figure 5). In the free
HX RNA, a fluorescence signal of intermediate intensity
originates from 2AP1493 sampling conformational space
with a preference for orientations outside the RNA helix.
Binding of aminoglycosides of the neomycin and kanamy-
cin families to the decoding site internal loop induces a
conformation in which fluorescence is quenched due to
expulsion of A1492 and mutual stacking of bases 1492
and 1493. Ligand interaction in the region adjacent to
the decoding site loop, which is the binding site for
hygromycin B, stabilizes non-canonical base pairs and
reduces flexibility of the sensor adenines such that
2AP1493 is locked in the rotated-out conformation
where its gives rise to high fluorescence. This indirect
effect on 2AP1493 fluorescence has been observed for
the aminoglycoside hygromycin B as well as Mg2+. We
are currently using the HX RNA in the screening for
new ligands that interact with helix h44 at both the
hygromycin B binding region and the decoding site.
Such ligands will be useful as tool compounds to study
ribosomal function and in the development of new
antibacterials.
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